|
US9340799B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
MRNA-sensing switchable gRNAs
|
|
US9322037B2
(en)
|
2013-09-06 |
2016-04-26 |
President And Fellows Of Harvard College |
Cas9-FokI fusion proteins and uses thereof
|
|
AU2015298571B2
(en)
|
2014-07-30 |
2020-09-03 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
|
WO2017070632A2
(en)
|
2015-10-23 |
2017-04-27 |
President And Fellows Of Harvard College |
Nucleobase editors and uses thereof
|
|
WO2018039438A1
(en)
|
2016-08-24 |
2018-03-01 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
|
KR20240007715A
(ko)
|
2016-10-14 |
2024-01-16 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵염기 에디터의 aav 전달
|
|
WO2018165504A1
(en)
|
2017-03-09 |
2018-09-13 |
President And Fellows Of Harvard College |
Suppression of pain by gene editing
|
|
KR20190123328A
(ko)
|
2017-03-09 |
2019-10-31 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
암 백신
|
|
CN110914310A
(zh)
|
2017-03-10 |
2020-03-24 |
哈佛大学的校长及成员们 |
胞嘧啶至鸟嘌呤碱基编辑器
|
|
EP3658573A1
(en)
|
2017-07-28 |
2020-06-03 |
President and Fellows of Harvard College |
Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace)
|
|
US12406749B2
(en)
|
2017-12-15 |
2025-09-02 |
The Broad Institute, Inc. |
Systems and methods for predicting repair outcomes in genetic engineering
|
|
WO2019226953A1
(en)
|
2018-05-23 |
2019-11-28 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
|
EP3820495A4
(en)
|
2018-07-09 |
2022-07-20 |
The Broad Institute Inc. |
RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES
|
|
WO2020092453A1
(en)
|
2018-10-29 |
2020-05-07 |
The Broad Institute, Inc. |
Nucleobase editors comprising geocas9 and uses thereof
|
|
US12351837B2
(en)
|
2019-01-23 |
2025-07-08 |
The Broad Institute, Inc. |
Supernegatively charged proteins and uses thereof
|
|
WO2020191241A1
(en)
|
2019-03-19 |
2020-09-24 |
The Broad Institute, Inc. |
Methods and compositions for editing nucleotide sequences
|
|
WO2020214842A1
(en)
|
2019-04-17 |
2020-10-22 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
US20220259617A1
(en)
|
2019-06-13 |
2022-08-18 |
The General Hospital Corporation |
Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells
|
|
US12435330B2
(en)
|
2019-10-10 |
2025-10-07 |
The Broad Institute, Inc. |
Methods and compositions for prime editing RNA
|
|
JP7785002B2
(ja)
|
2019-11-05 |
2025-12-12 |
ペアーワイズ プランツ サービシズ, インコーポレイテッド |
対立遺伝子のrnaにコードされたdnaの置換のための組成物および方法
|
|
CA3177481A1
(en)
|
2020-05-08 |
2021-11-11 |
David R. Liu |
Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
|
|
BR112023001272A2
(pt)
|
2020-07-24 |
2023-04-04 |
Massachusetts Gen Hospital |
Partículas semelhantes a vírus aprimoradas e métodos de uso das mesmas para entrega às células
|
|
KR20230091894A
(ko)
|
2020-10-21 |
2023-06-23 |
메사추세츠 인스티튜트 오브 테크놀로지 |
부위 특이적 표적화 요소를 통한 프로그램 가능한 첨가(paste)를 사용하는 부위 특이적 유전 공학을 위한 시스템, 방법, 및 조성물
|
|
AU2021374974A1
(en)
*
|
2020-11-06 |
2023-05-25 |
Pairwise Plants Services, Inc. |
Compositions and methods for rna-encoded dna-replacement of alleles
|
|
IL308836A
(en)
|
2021-05-28 |
2024-01-01 |
Sana Biotechnology Inc |
Lipid Particles Containing Baboon Truncated Endogenous Retrovirus (BAEV) Envelope Glycoprotein and Related Methods and Uses
|
|
CA3173953A1
(en)
*
|
2021-06-11 |
2023-12-10 |
Tyson D. BOWEN |
Rna polymerase iii promoters and methods of use
|
|
AU2022325955A1
(en)
|
2021-08-11 |
2024-02-08 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy to reduce instant blood mediated inflammatory reactions
|
|
CA3227108A1
(en)
|
2021-08-11 |
2023-02-16 |
Xiaomeng HU |
Genetically modified primary cells for allogeneic cell therapy
|
|
AU2022326565A1
(en)
|
2021-08-11 |
2024-02-08 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy
|
|
AU2022325231A1
(en)
|
2021-08-11 |
2024-02-08 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy to reduce complement-mediated inflammatory reactions
|
|
US20250313861A1
(en)
|
2021-10-22 |
2025-10-09 |
Sana Biotechnology, Inc. |
Methods of engineering allogeneic t cells with a transgene in a tcr locus and associated compositions and methods
|
|
EP4448775A1
(en)
|
2021-12-17 |
2024-10-23 |
Sana Biotechnology, Inc. |
Modified paramyxoviridae attachment glycoproteins
|
|
US20250059239A1
(en)
|
2021-12-17 |
2025-02-20 |
Sana Biotechnology, Inc. |
Modified paramyxoviridae fusion glycoproteins
|
|
US20250082777A1
(en)
|
2022-01-10 |
2025-03-13 |
Sana Biotechnology, Inc. |
Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses
|
|
WO2023150518A1
(en)
|
2022-02-01 |
2023-08-10 |
Sana Biotechnology, Inc. |
Cd3-targeted lentiviral vectors and uses thereof
|
|
WO2023150647A1
(en)
|
2022-02-02 |
2023-08-10 |
Sana Biotechnology, Inc. |
Methods of repeat dosing and administration of lipid particles or viral vectors and related systems and uses
|
|
WO2023158836A1
(en)
|
2022-02-17 |
2023-08-24 |
Sana Biotechnology, Inc. |
Engineered cd47 proteins and uses thereof
|
|
WO2023192655A2
(en)
*
|
2022-04-01 |
2023-10-05 |
Prime Medicine, Inc. |
Methods and compositions for editing nucleotide sequences
|
|
WO2023205694A2
(en)
*
|
2022-04-20 |
2023-10-26 |
Tacit Therapeutics, Inc. |
Stabilization of therapeutic trans-splicing rna molecules in human cells
|
|
WO2023215831A1
(en)
*
|
2022-05-04 |
2023-11-09 |
Tome Biosciences, Inc. |
Guide rna compositions for programmable gene insertion
|
|
WO2023220672A1
(en)
*
|
2022-05-13 |
2023-11-16 |
The Regents Of The University Of California |
Compositions and methods for rna editing
|
|
CN121826033A
(zh)
*
|
2022-05-25 |
2026-04-10 |
中国科学院遗传与发育生物学研究所 |
一种在基因组中定点插入外源序列的方法
|
|
US20250354177A1
(en)
*
|
2022-05-30 |
2025-11-20 |
Wuhan University |
System and methods for duplicating target fragments
|
|
US20260185068A1
(en)
*
|
2022-06-02 |
2026-07-02 |
Univesity Of Massachusetts |
High fidelity nucleotide polymerase chimeric prime editor systems
|
|
CN114958767B
(zh)
*
|
2022-06-02 |
2022-12-27 |
健颐生物科技发展(山东)有限公司 |
基于hiPSC细胞构建的神经干细胞制剂的制备方法
|
|
CN115948461A
(zh)
*
|
2022-07-14 |
2023-04-11 |
五邑大学 |
一种双向导碱基基因编辑系统及其应用
|
|
EP4562142A1
(en)
*
|
2022-07-27 |
2025-06-04 |
Inscripta, Inc. |
Modulating cellular repair mechanisms for genomic editing
|
|
CN116064517A
(zh)
*
|
2022-07-29 |
2023-05-05 |
之江实验室 |
一种先导编辑gRNA的产生方式及其用途
|
|
WO2024044655A1
(en)
|
2022-08-24 |
2024-02-29 |
Sana Biotechnology, Inc. |
Delivery of heterologous proteins
|
|
WO2024064761A2
(en)
*
|
2022-09-20 |
2024-03-28 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions to control gene using genome editing
|
|
CN115948449B
(zh)
*
|
2022-09-20 |
2026-03-27 |
浙江大学杭州国际科创中心 |
一种适用于酵母先导编辑的双质粒系统及应用
|
|
EP4590688A1
(en)
|
2022-09-21 |
2025-07-30 |
Sana Biotechnology, Inc. |
Lipid particles comprising variant paramyxovirus attachment glycoproteins and uses thereof
|
|
WO2024077267A1
(en)
|
2022-10-07 |
2024-04-11 |
The Broad Institute, Inc. |
Prime editing methods and compositions for treating triplet repeat disorders
|
|
EP4602174A1
(en)
|
2022-10-13 |
2025-08-20 |
Sana Biotechnology, Inc. |
Viral particles targeting hematopoietic stem cells
|
|
WO2024086586A2
(en)
*
|
2022-10-18 |
2024-04-25 |
Flagship Pioneering Innovations Vi, Llc |
Improved gene editing systems utilizing trans recruiting components
|
|
WO2024097313A1
(en)
|
2022-11-02 |
2024-05-10 |
Sana Biotechnology, Inc. |
Methods for producing t cell therapy products
|
|
WO2024119157A1
(en)
|
2022-12-02 |
2024-06-06 |
Sana Biotechnology, Inc. |
Lipid particles with cofusogens and methods of producing and using the same
|
|
WO2024151541A1
(en)
|
2023-01-09 |
2024-07-18 |
Sana Biotechnology, Inc. |
Type-1 diabetes autoimmune mouse
|
|
US20260218188A1
(en)
*
|
2023-01-18 |
2026-07-30 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Antisense oligonucleotides for rna editing and methods for using the same
|
|
WO2024168116A1
(en)
|
2023-02-08 |
2024-08-15 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treatment of myotonic dystrophy
|
|
EP4662306A2
(en)
|
2023-02-09 |
2025-12-17 |
The Broad Institute Inc. |
Evolved recombinases for editing a genome in combination with prime editing
|
|
WO2024170866A1
(en)
*
|
2023-02-16 |
2024-08-22 |
Genome Research Limited |
Methods for modifying a cell genome
|
|
WO2024206125A1
(en)
*
|
2023-03-24 |
2024-10-03 |
The Broad Institute, Inc. |
Use of prime editing for treating sickle cell disease
|
|
WO2024215712A2
(en)
*
|
2023-04-11 |
2024-10-17 |
University Of Washington |
Methods for identifying epigenetic factors influencing gene editing and modulating gene editing outcome via epigenetic modulation
|
|
WO2024220135A1
(en)
|
2023-04-17 |
2024-10-24 |
University Of Massachusetts |
Prime editing systems having pegrna with reduced auto-inhibitory interaction
|
|
WO2024220598A2
(en)
|
2023-04-18 |
2024-10-24 |
Sana Biotechnology, Inc. |
Lentiviral vectors with two or more genomes
|
|
EP4698666A1
(en)
|
2023-04-18 |
2026-02-25 |
Sana Biotechnology, Inc. |
Universal protein g fusogens and adapter systems thereof and related lipid particles and uses
|
|
WO2024220560A1
(en)
|
2023-04-18 |
2024-10-24 |
Sana Biotechnology, Inc. |
Engineered protein g fusogens and related lipid particles and methods thereof
|
|
CN121843705A
(zh)
|
2023-05-03 |
2026-04-10 |
萨那生物科技公司 |
工程化胰岛细胞的给药和施用方法
|
|
WO2024243236A2
(en)
|
2023-05-22 |
2024-11-28 |
Sana Biotechnology, Inc. |
Methods of delivery of islet cells and related methods
|
|
AU2024274792A1
(en)
|
2023-05-23 |
2025-10-23 |
Sana Biotechnology, Inc. |
Tandem fusogens and related lipid particles
|
|
KR20260028193A
(ko)
|
2023-05-23 |
2026-03-03 |
더 브로드 인스티튜트, 인코퍼레이티드 |
개선된 에디팅 효율을 갖는 진화 및 조작된 프라임 에디터
|
|
WO2025022290A1
(en)
|
2023-07-21 |
2025-01-30 |
Crispr Therapeutics Ag |
Modulating expression of alas1 (5'-aminolevulinate synthase 1) gene
|
|
WO2025038881A1
(en)
*
|
2023-08-16 |
2025-02-20 |
Beam Therapeutics Inc. |
Prime editing of single base mutations in sickle cell disease
|
|
WO2025049563A1
(en)
*
|
2023-08-28 |
2025-03-06 |
University Of Florida Research Foundation, Inc. |
A programmable gene correction technology using cas-polymerase constructs
|
|
EP4771154A2
(en)
*
|
2023-09-01 |
2026-07-08 |
Renagade Therapeutics Management Inc. |
Gene editing systems, compositions, and methods for treatment of vexas syndrome
|
|
WO2025054202A1
(en)
|
2023-09-05 |
2025-03-13 |
Sana Biotechnology, Inc. |
Method of screening a sample comprising a transgene with a unique barcode
|
|
WO2025076306A1
(en)
|
2023-10-06 |
2025-04-10 |
University Of Massachusetts |
Prime editors having improved prime editing efficiency
|
|
WO2025096936A2
(en)
|
2023-11-03 |
2025-05-08 |
The Broad Institute, Inc. |
Use of prime editing in correcting mutations in cdkl5
|
|
WO2025111452A2
(en)
*
|
2023-11-21 |
2025-05-30 |
Prime Medicine, Inc. |
CHEMICAL MODIFICATIONS IN PEgRNA and ngRNAs
|
|
KR102969401B1
(ko)
*
|
2023-11-21 |
2026-05-29 |
경상국립대학교산학협력단 |
교정 정밀도가 향상된 프라임 에디팅 시스템 및 이의 용도
|
|
CN117497092B
(zh)
*
|
2024-01-02 |
2024-05-14 |
微观纪元(合肥)量子科技有限公司 |
基于动态规划和量子退火的rna结构预测方法及系统
|
|
WO2025151814A1
(en)
|
2024-01-10 |
2025-07-17 |
The Broad Institute, Inc. |
Use of prime editing in correcting mutations in cftr
|
|
AU2025208175A1
(en)
|
2024-01-12 |
2026-06-25 |
Sana Biotechnology, Inc. |
Safety switches to control in vitro and in vivo proliferation of cell therapy products
|
|
EP4600357A1
(en)
*
|
2024-02-12 |
2025-08-13 |
Technische Universität München |
Delivery system for gene editing tools
|
|
WO2025184529A1
(en)
|
2024-03-01 |
2025-09-04 |
Sana Biotechnology, Inc. |
Viral particles with fusogen display and related compositions and methods
|
|
WO2025188921A1
(en)
|
2024-03-06 |
2025-09-12 |
Mdx Management Llc |
Shp-1 inhibitors and activators of t cells
|
|
WO2025212519A1
(en)
|
2024-04-01 |
2025-10-09 |
Moonlight Bio, Inc. |
Dll3 binding proteins and uses thereof
|
|
US20250313863A1
(en)
*
|
2024-04-09 |
2025-10-09 |
Trustees Of Boston University |
ENGINEERED CIRCULARIZED pegRNAs AND USES THEREOF
|
|
WO2025217616A1
(en)
|
2024-04-12 |
2025-10-16 |
The Broad Institute, Inc. |
Prime editing and base editing of the atp1a3 gene for the treatment of alternating hemiplegia of childhood
|
|
WO2025235828A2
(en)
*
|
2024-05-08 |
2025-11-13 |
The General Hospital Corporation |
Engineered prime editors for treating genetic deafness
|
|
WO2025240795A1
(en)
*
|
2024-05-15 |
2025-11-20 |
President And Fellows Of Harvard College |
End-modified grnas for improved base editing
|
|
WO2025250677A1
(en)
*
|
2024-05-28 |
2025-12-04 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for correction of trex1 mutations
|
|
CN118581153A
(zh)
*
|
2024-08-05 |
2024-09-03 |
崖州湾国家实验室 |
Dna聚合酶介导的核苷酸序列编辑方法及组合物
|
|
WO2026055354A2
(en)
*
|
2024-09-04 |
2026-03-12 |
University Of Massachusetts |
Prime editing with modification-tolerant polymerases
|
|
WO2026069163A1
(en)
|
2024-09-25 |
2026-04-02 |
Crispr Therapeutics Ag |
Differentiation method for producing immature beta cells
|
|
WO2026106945A2
(en)
|
2024-11-12 |
2026-05-21 |
The Broad Institute, Inc. |
Engineered prime editing guide rnas and methods of making and using same
|